High-Flow Versus VenturiMask Oxygen Therapy to Prevent Reintubation in Hypoxemic Patients after Extubation: A Multicenter Randomized Clinical Trial
adverse event
oxygen therapy
Respiratory failure
Acute respiratory failure
hazard ratio
Mechanical ventilation
0302 clinical medicine
acute respiratory failure; nasal high-flow oxygen; noninvasive ventilation; oxygen therapy; weaning
nasal high-flow oxygen
middle aged
odds ratio
endotracheal intubation
Horowitz index
weaning
adult
clinical trial
3. Good health
female
Respiratory Insufficiency
Noninvasive ventilation
extubation
610
Weaning
reintubation
Article
intubation
03 medical and health sciences
male
Intubation, Intratracheal
Humans
controlled study
human
acute respiratory failure
hypoxemia
Noninvasive Ventilation
respiratory failure
Oxygen Inhalation Therapy
noninvasive ventilation
High-flow nasal oxygen
Oxygen therapy
major clinical study
Oxygen
High-flow nasal oxygen; Mechanical ventilation; Noninvasive ventilation; Respiratory failure; Weaning
multicenter study
confidence interval
randomized controlled trial
treatment outcome
Airway Extubation
[SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract
Nasal high-flow oxygen
oxygen
high flow nasal cannula therapy
DOI:
10.1164/rccm.202201-0065oc
Publication Date:
2022-07-18T19:54:47Z
AUTHORS (60)
ABSTRACT
Rationale: When compared with VenturiMask after extubation, high-flow nasal oxygen provides physiological advantages. Objectives: To establish whether prevents endotracheal reintubation in hypoxemic patients VenturiMask. Methods: In this multicenter randomized trial, 494 exhibiting PaO2:FiO2 ratio ⩽ 300 mm Hg extubation were randomly assigned to receive or oxygen, the possibility apply rescue noninvasive ventilation before reintubation. High-flow use group was not permitted. Measurements and Main Results: The primary outcome rate of within 72 hours according predefined criteria, which validated a posteriori by an independent adjudication committee. secondary outcomes included at 28 days need for criteria. After intubation criteria validation (n = 492 patients), 32 (13%) 27 (11%) required (unadjusted odds ratio, 1.26 [95% confidence interval (CI), 0.70–2.26]; P 0.49). At days, 21% 23% (adjusted hazard 0.89 CI, 0.60–1.31]; 0.55). significantly lower than group: hours, 8% versus 17% 0.39 0.22–0.71]; 0.002) 12% 0.52 0.32–0.83]; 0.007). Conclusions: Reintubation did differ between treated extubation. yielded less frequent ventilation. Clinical trial registered www.clinicaltrials.gov (NCT02107183).
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (56)
CITATIONS (30)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....